Research summaries for everyoneNot medical advice
Tissue Repair research area, Elevated Pharma

Research area

Tissue Repair

Tendon, wound and connective-tissue models — and where human evidence is still missing.

2 references14 key studies

Tissue Repair references

Research updates

Recent developments

The latest dated changes for tissue repair references. See all research updates.

  1. HHS interim compounding policy

    HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.

    Read the source
  2. Orthopaedic review

    A JAAOS review of BPC-157, thymosin beta-4 and TB-500 finds mostly preclinical evidence.

    Read the source
  3. FDA advisory committee votes

    FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).

    Read the source
  4. Category 2 removals

    FDA announced the removal of 12 peptide substances from its Category 2 compounding list, effective about April 22, 2026. Removal is not approval.

    Read the source